TELL
PrivateLast Round
Grant
May 1, 2025
Momentum
Top 25%
of companies Caplight tracks
Company Overview
TELL is a health technology company that provides a web-based platform for automated speech and language analysis to assess and monitor neurocognitive health.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, NLP & Conversational AI, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TELL Comparables
Compare TELL with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LangAware | 89% | |
| Novoic | 83% | |
| Redenlab | 79% | |
TELL Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 1, 2025 | ||||
| Accelerator | Oct 24, 2024 | ||||
| Accelerator | Jul 26, 2024 |
Key People
Founding team and executive leadership
TELL Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| StartUp Health | Accelerator |
| Agencia Nacional de Investigación e Innovación | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors grew 84% MoM, from 322 to 592.
- Jul 26, 2024
Secured funding from StartUp Health.
TELL Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TELL's valuation, stock price, and market status.